AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research

Latest pharma news updates

To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has included the development of novel drug delivery approaches to enhance anti-tumor immune response and incorporating unique 3D screening methodologies for selecting novel therapeutic molecules.

"Our oncology collaboration with the University of Chicago enables us to combine our expertise in understanding the underlying biology in key areas of interest, such as immuno-oncology, oncogenic pathways, and biomarkers of drug sensitivity or disease," said Steve Davidsen, Vice President, Oncology Discovery Research at AbbVie. "This effort drives towards a common goal of accelerating discovery efforts and delivering novel therapies to people living with cancer." 

Continuing the intent of the initial research collaboration, the extension of the collaboration is designed to further accelerate and advance medical research in oncology at both organizations.

"Our ambition is that the clinical and translational collaboration between AbbVie and the University of Chicago continues to impact public health positively," said Kunle Odunsi, M.D., Ph.D., AbbVie Foundation Director, University of Chicago Medicine Comprehensive Cancer Center. "The collaboration has created valuable opportunities for scientific exchange and the development of clinical trials for cancer research."

Under the agreement, the organizations will continue working together to advance research in several areas, focusing on oncology, and AbbVie gains an option for an exclusive license to certain University of Chicago discoveries made as part of the collaboration.

"We look forward to more discoveries together in the years to come," said Juan de Pablo, University of Chicago Vice President for National Laboratories, Science Strategy, Innovation, and Global Initiatives. "The extension of our agreement will continue to provide faculty and students with opportunities to work with colleagues at a global biopharmaceutical leader and translate their findings from the lab into the real world. It will enable the kind of preclinical research that is needed to help lay the foundations for better approaches and treatments with the goal to ultimately improve quality of life for patients."

Tags : #Abbvie #UniversityofChicago #Oncology #SteveDavidsen

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FORSYS Inc opens new office in financial districtFebruary 29, 2024
The Rise in Patients Requiring Revision Hip Replacement SurgeryFebruary 29, 2024
Aakash Launches Study Material in BengaliFebruary 29, 2024
Harmony in Action: Nisarg Srishti's Dual Impact Initiative Unleashes a Symphony of Change at Sane Guruji Shikshan Sanshtha, Pragati VidyalayaFebruary 29, 2024
Wearable Tech in the Bedroom: Introducing Loop, MyMuse’s Vibrating Ring Massager for MenFebruary 28, 2024
TechInvention Lifecare announces the ground breaking of its state-of-the-art Global Collaborative Centre for Medical Countermeasures February 28, 2024
Endocrine Disorders: Causes, Tests And TreatmentFebruary 28, 2024
Çelebi Delhi Cargo Terminal Management Bolsters Security and Efficiency with "CargoCEL," Barcode Scanning UpgradeFebruary 28, 2024
Venkaiah Naidu unveiled a book “There I Was” authored by Mrs Aruna Ravi KumarFebruary 27, 2024
Maxivision Super Specialty Eye Hospitals introduces Schwind Amaris 500, a state-of-the-art German InnovationFebruary 27, 2024
Maximising circular economy strategies for rare earth elements supplyFebruary 27, 2024
FICCI Ladies Organization organised an interaction with one of the doyens of the Indian IT industry Dr BVR Mohan ReddyFebruary 27, 2024
Nat Habit strengthens leadership to accelerate its growth journey to 500 Cr; onboards Ankita Srivastava (ex-L’Oreal, Reckitt, Marico, Raymond Consumer Care) as Chief Marketing OfficerFebruary 27, 2024
Shiprocket Launches Aarambh 2024 for Women-Led SMEs NationwideFebruary 27, 2024
Treatment is prevention: Stop the spread of infection by finding all and treating all TBFebruary 27, 2024
Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics February 26, 2024
FICCI Ladies Organization organized an interaction with one of the doyens of Indian IT industry Dr BVR Mohan ReddyFebruary 26, 2024
Former Secretary General of SCSC, Krishna Yedula conferred with Doctorate in HumanityFebruary 25, 2024
Project Champion School Games held February 25, 2024
Daksha 3.0, a nation level techno-test organised by Anurag University concludedFebruary 25, 2024